{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:16:44Z","timestamp":1788016604344,"version":"build-2784847793"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,29]]},"DOI":"10.7759\/cureus.115399","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:33:06Z","timestamp":1788013986000},"source":"Crossref","is-referenced-by-count":0,"title":["Skin Deep: A Case Report of Erythema Nodosum Induced by Dupilumab Therapy"],"prefix":"10.7759","author":[{"given":"Nisat","family":"Tasnim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrin","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Alhashimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Malana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobanjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nailah","family":"Sayeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizaaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel S","year":"2016","unstructured":"Wenzel S, Castro M, Corren J, et al.. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016, 388:31-44. 10.1016\/S0140-6736(16)30307-5","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0702-4","article-title":"Liberty asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy\/safety in patients with uncontrolled, moderate-to-severe asthma","volume":"35","author":"Busse WW","year":"2018","unstructured":"Busse WW, Maspero JF, Rabe KF, et al.. Liberty asthma QUEST: phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy\/safety in patients with uncontrolled, moderate-to-severe asthma. Adv Ther. 2018, 35:737-48. 10.1007\/s12325-018-0702-4","journal-title":"Adv Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe KF","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, et al.. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018, 378:2475-85. 10.1056\/NEJMoa1804093","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000530608","article-title":"Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review","volume":"239","author":"Su Z","year":"2023","unstructured":"Su Z, Zeng YP. Dupilumab-associated psoriasis and psoriasiform manifestations: a scoping review. Dermatology. 2023, 239:646-57. 10.1159\/000530608","journal-title":"Dermatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2011.03522.x","article-title":"Interleukin-23: as a drug target for autoimmune inflammatory diseases","volume":"135","author":"Tang C","year":"2012","unstructured":"Tang C, Chen S, Qian H, Huang W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology. 2012, 135:112-24. 10.1111\/j.1365-2567.2011.03522.x","journal-title":"Immunology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01332.x","article-title":"Erythema nodosum and erythema induratum (nodular vasculitis): diagnosis and management","volume":"23","author":"Gilchrist H","year":"2010","unstructured":"Gilchrist H, Patterson JW. Erythema nodosum and erythema induratum (nodular vasculitis): diagnosis and management. Dermatol Ther. 2010, 23:320-7. 10.1111\/j.1529-8019.2010.01332.x","journal-title":"Dermatol Ther"},{"key":"ref7","article-title":"Erythema nodosum: a sign of systemic disease","volume":"75","author":"Schwartz RA","year":"2007","unstructured":"Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007, 75:695-700.","journal-title":"Am Fam Physician"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.11.007","article-title":"Dupilumab-induced erythema nodosum","volume":"19","author":"Mustin DE","year":"2022","unstructured":"Mustin DE, Cole EF, Blalock TW, Kuruvilla ME, Stoff BK, Feldman RJ. Dupilumab-induced erythema nodosum. JAAD Case Rep. 2022, 19:41-3. 10.1016\/j.jdcr.2021.11.007","journal-title":"JAAD Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90333-6","article-title":"The effects of glucocorticoids on human eosinophils","volume":"94","author":"Schleimer RP","year":"1994","unstructured":"Schleimer RP, Bochner BS. The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol. 1994, 94:1202-13. 10.1016\/0091-6749(94)90333-6","journal-title":"J Allergy Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.050","article-title":"Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database","volume":"86","author":"Bettuzzi T","year":"2022","unstructured":"Bettuzzi T, Drucker A, Staumont-Sall\u00e9 D, Bihan K, Lebrun-Vignes B, Sbidian E. Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database. J Am Acad Dermatol. 2022, 86:431-3. 10.1016\/j.jaad.2021.09.050","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v11.i26.6154","article-title":"Mepolizumab induced palmoplantar psoriasis: a case report","volume":"11","author":"Artosi F","year":"2023","unstructured":"Artosi F, Diluvio L, Vultaggio M, Campione E, Bianchi L. Mepolizumab induced palmoplantar psoriasis: a case report. World J Clin Cases. 2023, 11:6154-8. 10.12998\/wjcc.v11.i26.6154","journal-title":"World J Clin Cases"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/512901-skin-deep-a-case-report-of-erythema-nodosum-induced-by-dupilumab-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:33:07Z","timestamp":1788013987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/512901-skin-deep-a-case-report-of-erythema-nodosum-induced-by-dupilumab-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.115399","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,29]]}}}